Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 4,952 $ 32,190
Marketable securities, current   28,859
Prepaid expenses 3,887 3,459
Grants revenue receivable 274  
Other current assets 2,710 3,790
Total current assets 11,823 68,298
Operating lease right-of-use assets 10,163 11,132
Property and equipment, net 10,158 14,632
Other assets 3,368 3,486
Total assets 35,512 97,548
Current liabilities:    
Accounts payable 4,669 504
Accrued liabilities 3,510 8,823
Deferred revenue, current 16,409 45,573
Other current liabilities 2,349 2,182
Total current liabilities 26,937 57,082
Deferred revenue, long-term 19 5,904
Long-term debt, net of current portion   36,168
Operating lease liabilities, long term portion 11,029 12,231
Contingent value right liability 4,856  
Other liabilities 1,349 1,295
Total liabilities 44,190 112,680
Commitments and contingencies (Note 10)
Stockholders' deficit    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares as of June 30, 2023 and December 31, 2022; issued and outstanding: 250 shares at June 30, 2023 and December 31, 2022
Common stock, $0.001 par value: Authorized: 150,000,000 shares as of June 30, 2023 and December 31, 2022; issued and outstanding: 56,351,647 shares at June 30, 2023 and December 31, 2022 56 56
Additional paid-in capital 436,056 429,646
Accumulated other comprehensive income/(loss) 1 (66)
Accumulated deficit (444,791) (444,768)
Total stockholders' deficit (8,678) (15,132)
Total liabilities and stockholders' deficit $ 35,512 $ 97,548